US state receives 4,20,000 from Ranbaxy

The US state of Idaho has said it has received almost 420,000 from drug major Ranbaxy as part of a 500 million settlement that the Indian firm had signed with US authorities.

The settlement resolves civil and criminal allegations that Ranbaxy introduced adulterated drugs into interstate commerce,and,as a result,false or fraudulent claims were submitted to Idaho Medicaid,the US state said.